WG3: Commercialisation pathways for medical devices
This group supports the commercial translation of EM therapeutic technologies through two focus areas:
- provide and support training on clinical need assessment, market analysis, IP evaluation, paths to market,
- create novel guidelines for successful translation of EM medical devices, to streamline the commercialisation process for engineers working on medical device development.
You can download the latest progress report here.
Translation and commercialisation of EM medical technologies: guidelines and recommendations.
We understand that taking an idea for innovation through to a product that can be used in healthcare systems is challenging. That is why we created this suite of innovation tools on all stages of the innovation pathway from prioritisation to adoption to inform and support all innovators at each stage. These tools can be used as a guide and combined with other resources and knowledge to help you through your innovation journey. You can download the guidelines here.
WG3 report on data user requirements :
